A phase II study of lapatinib and capecitabine in second-line treatment of metastatic pancreatic cancer.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2598040025
